Strongyloides is a parasitic roundworm, most commonly the species Strongyloides stercoralis, that infects an estimated tens of millions of people worldwide yet remains one of the most underdiagnosed parasitic infections in medicine. What makes it unusual among human parasites is its ability to complete its entire lifecycle inside a single host, re-infecting the same person over and over without any new exposure to contaminated soil. This autoinfection cycle means a person can carry the worm for decades, sometimes with few or no symptoms, until something suppresses their immune system and the infection explodes into a life-threatening emergency.
How You Get Infected
Strongyloides larvae live in warm, moist soil, typically in tropical and subtropical regions. Infection starts when the microscopic infective-stage larvae penetrate exposed skin, usually the feet, of someone walking barefoot or working in contaminated ground.1PubMed Central. The Worm that Clogs the Lungs: Strongyloides Hyper-Infection Leading to Fatal Acute Respiratory Distress Syndrome (ARDS) Larvae can also be ingested, though skin penetration is the classic route.2PubMed Central. Strongyloides stercoralis From the skin, the larvae enter the bloodstream or lymphatic vessels, travel to the lungs, burrow into the air sacs, get coughed up into the throat, and are swallowed into the gut, where they mature into adult worms in the small intestine. This roundabout journey through the lungs and back to the gut mirrors what hookworms do, but strongyloides has a trick that hookworms lack.
The larvae do not passively wait for a foot to step on them. Research on how infective larvae find hosts reveals that they actively seek out warmth, migrating up thermal gradients toward body heat.3PubMed Central. Invade or die: behaviours and biochemical mechanisms that drive skin penetration in Strongyloides and other skin-penetrating nematodes – Section: The role of sensory cues in stimulating skin penetration They are also attracted to sodium chloride at concentrations found in human sweat and to a range of skin odorants, many of which overlap with the chemical cues that attract mosquitoes to people.4PLoS Pathogens. Diverse Host-Seeking Behaviors of Skin-Penetrating Nematodes In lab experiments, sodium chloride at around 0.05 molar concentration attracted the most larvae, while other salts like potassium chloride failed to draw them in.5The Southeast Asian journal of tropical medicine and public health. Host-finding behavior of Strongyloides stercoralis infective larvae to sodium cation, human serum, and sweat
Once larvae contact skin, they secrete a powerful metalloprotease enzyme with elastase activity that breaks down the connective tissue matrix of the dermis, essentially dissolving a path through your skin. Blocking this enzyme with metalloprotease inhibitors prevents skin penetration in laboratory models, confirming the enzyme is essential for the parasite’s entry.6Experimental Parasitology. Strongyloides stercoralis: Identification of a protease that facilitates penetration of skin by the infective larvae The gene encoding this enzyme, called strongylastacin, is switched on only in the infective larval stage, highlighting how tightly the parasite’s molecular machinery is tuned to the moment of invasion.7PubMed. Identification of an astacin-like metallo-proteinase transcript from the infective larvae of Strongyloides stercoralis
The Autoinfection Cycle
Most intestinal worms have a straightforward lifecycle: eggs or larvae leave the body in stool, develop in the environment, and infect a new host. Strongyloides can do that too, but it can also skip the environment entirely. Eggs hatched inside the gut produce larvae that transform into the infective stage right there in the intestine. These larvae penetrate the gut wall or the skin around the anus and re-enter the bloodstream, completing the lung-to-gut circuit all over again without ever leaving the body.8PubMed Central. Twenty-five Years of Chronic Strongyloidiasis in an Immigrant This is the autoinfection cycle, and it is unique to strongyloides among human helminths.
The practical consequence is striking. A person who was infected decades ago in a tropical country and has lived in a temperate climate ever since, with zero re-exposure to contaminated soil, can still harbor active worms. Case reports describe chronic strongyloidiasis persisting for 75 years after the patient left an area where the parasite is common.9PubMed Central. Strongyloidiasis after 75 Years In a healthy person with an intact immune system, autoinfection is kept in check at a low level; the worm population stays small, and many carriers are completely asymptomatic. The danger arrives when immune control breaks down.
When the Balance Tips — Hyperinfection and Dissemination
In immunosuppressed patients, the low-grade autoinfection cycle can accelerate dramatically. The worm population multiplies unchecked, and larvae spread beyond their normal territory of the gut, lungs, and skin into organs like the liver, brain, and heart. This is hyperinfection syndrome, and when larvae spill into organs not ordinarily involved, it becomes disseminated strongyloidiasis. Both are medical emergencies. The massive larval migration damages the gut lining, allowing intestinal bacteria to hitch a ride into the bloodstream. The result is systemic bacterial sepsis and multiorgan failure, with mortality rates that can exceed half of diagnosed cases.10BMJ. Strongyloides stercoralis infection
The single most common trigger is corticosteroid use.11PubMed Central. Strongyloides hyperinfection syndrome due to corticosteroid therapy after resection of meningioma: illustrative case This does not require a long course of high-dose steroids. One published case involved a pregnant woman who received a single 8-milligram dose of dexamethasone before an emergency cesarean section to help mature the baby’s lungs. Eight days later, she developed full-blown hyperinfection syndrome.12PubMed Central. Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development The COVID-19 pandemic brought this risk into sharper focus, because dexamethasone became a standard treatment for severe COVID. Clinicians in regions where strongyloides is common began reporting hyperinfection cases in patients who had been carrying the worm silently for years and were then given corticosteroids for their lung disease.13Emerging Infectious Diseases. Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
Co-infection with HTLV-1, a human retrovirus common in parts of the Caribbean, South America, and Japan, is the other major risk factor. HTLV-1 shifts the infected person’s immune response away from the type needed to control worms. Patients co-infected with HTLV-1 show lower levels of the immune signals that drive worm killing and higher levels of signals that suppress that response, effectively dismantling the defense against strongyloides.14PubMed. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis Solid organ transplant recipients are another high-risk group, discussed below.
How the Immune System Normally Keeps It in Check
A healthy person’s immune system does not eliminate strongyloides outright but maintains a tenuous equilibrium that prevents the worm from multiplying out of control. In mouse models, eosinophils are the first responders during initial infection, directly killing larvae. Neutrophils and eosinophils are both drawn to the parasites, releasing toxic granule proteins that damage and destroy them.15PubMed Central. Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model Eosinophils also help prime the adaptive immune response, presenting pieces of the parasite to other immune cells to build longer-term protection.16PubMed Central. Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice This explains why drugs or diseases that suppress eosinophil function or dampen the type of immune response that targets worms can tip the balance so catastrophically.
One complication sometimes seen even in immunocompetent patients with chronic infection is protein-losing enteropathy, where the parasite’s presence in the gut wall causes protein to leak from the blood into the intestinal lumen. In one reported case, a patient on long-term corticosteroids for another condition was found to have dilated lymphatic vessels throughout the small intestine on endoscopy, with strongyloides larvae identified in the stomach and duodenum on biopsy.17PubMed Central. Gastroduodenal strongyloidiasis infection causing protein-losing enteropathy: A case report and review of the literature
Symptoms That Are Easy to Miss
Most people with chronic strongyloides have no symptoms at all, or only vague complaints that do not point to a parasite: intermittent abdominal pain, loose stools, occasional nausea. When the larvae migrate through the lungs, some people develop a dry cough or wheezing that can be mistaken for asthma. Skin symptoms can include an intermittent itchy rash, typically around the buttocks, groin, or trunk, that comes and goes unpredictably.
The most distinctive skin sign is larva currens, a rapidly advancing, serpiginous (snake-like) streak of redness and hives that races across the skin at a pace visible in real time, sometimes covering several centimeters per hour. It is caused by larvae migrating through the skin during the autoinfection cycle. The speed and fleeting nature of this rash distinguish it from the slower-moving tracks caused by other parasites like hookworm larva migrans, but the rash appears unpredictably and vanishes within hours, making it easy to miss in a clinical visit.18PubMed Central. Larva Currens: Report of Seven Cases and Literature Review
Why Diagnosis Is So Difficult
Strongyloides is often called the most underdiagnosed parasitic infection in medicine, and the reasons are partly biological and partly practical. The parasite sheds larvae into stool irregularly and in small numbers during chronic infection, so a single stool sample examined under a microscope has a terrible chance of catching them. In one study from Ethiopia comparing five diagnostic methods, the standard stool concentration technique picked up only about 2% of infections, while a molecular test (RT-PCR) found roughly 29%.19PubMed Central. Evaluation of five diagnostic methods for Strongyloides stercoralis infection in Amhara National Regional State, northwest Ethiopia Even PCR across multiple studies has a pooled sensitivity of only around 62%, rising to about 72% when certain comparison biases are removed.20PLoS Neglected Tropical Diseases. Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection—A systematic review and meta-analysis
More labor-intensive parasitological methods do better. Agar plate culture, where a stool sample is placed on a nutrient agar plate and incubated for days so that larvae crawl outward leaving visible tracks, achieved nearly 98% sensitivity in one evaluation in Addis Ababa.21PubMed Central. Evaluation of Parasitological Methods for the Detection of Strongyloides Stercoralis among Individuals in Selected Health Institutions In Addis Ababa, Ethiopia But agar plate culture requires specialized equipment and days of incubation, making it impractical for routine screening in busy clinics or field settings.
Blood-based antibody tests (serology) offer a more convenient alternative for screening. The best-performing commercial ELISA kits achieve sensitivities above 90% with specificities above 97%, and a newer test using a recombinant antigen called NIE approaches 100% specificity, meaning almost no false positives, while still maintaining workable sensitivity.22PubMed Central. Diagnostic Accuracy of Five Serologic Tests for Strongyloides stercoralis Infection A field study in Ecuador confirmed that combining an ELISA with either PCR or the Baermann stool concentration technique gave the best balance of positive and negative predictive values in a community screening setting.23The Lancet Infectious Diseases. Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador The catch with serology is that antibodies can persist after successful treatment, so a positive result does not always mean active infection, which complicates follow-up.
The net effect of all this diagnostic difficulty is massive global underestimation. In many endemic countries, prevalence surveys rely on basic stool microscopy, which misses the majority of carriers. A review from Ethiopia described the infection as “the most neglected tropical disease” in the country, with its true burden obscured by insensitive tests and the asymptomatic nature of most cases.24PubMed Central. Strongyloidiasis: the most neglected tropical disease in Ethiopia25PLOS Neglected Tropical Diseases. Strongyloidiasis—An Insight into Its Global Prevalence and Management
Treatment
Ivermectin is the drug of choice for strongyloides and it works well. In a randomized trial comparing a single oral dose of ivermectin against a week-long course of albendazole (the other commonly available deworming drug), ivermectin cured roughly 97% of patients compared with about 63% for albendazole. The albendazole group also had a far higher rate of later relapse or reinfection.26PLOS Neglected Tropical Diseases. Efficacy and Safety of Single and Double Doses of Ivermectin versus 7-Day High Dose Albendazole for Chronic Strongyloidiasis Another trial found ivermectin cure rates of roughly 89% versus about 50% for albendazole, reinforcing the same pattern.27PubMed. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis
A question clinicians have wrestled with is whether multiple doses of ivermectin do better than a single dose for uncomplicated chronic infection. A large phase 3 trial settled this: a single dose cured about 86% of patients at one year, while four doses cured about 85%, a difference that was not statistically meaningful. The multi-dose regimen was also tolerated less well. For non-disseminated strongyloidiasis, a single dose is now the preferred approach.28The Lancet Infectious Diseases. Efficacy of single dose versus multidose ivermectin for the treatment of strongyloidiasis (IVIRM): a multicentre, open-label, phase 3, randomised controlled superiority trial Hyperinfection or disseminated disease is a different story; these patients typically require prolonged, sometimes daily ivermectin courses, and even with treatment, mortality remains high.
The Organ Transplant Problem
Solid organ transplantation creates a perfect storm for strongyloides. Recipients receive potent immunosuppressive drugs, often including corticosteroids, to prevent organ rejection. If the recipient or the donor carries the parasite, the post-transplant immune suppression can unleash hyperinfection. Donor-derived strongyloides infection is uncommon but well documented and sometimes fatal.29Case Reports in Transplantation. Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
A CDC investigation covering cases from 2012 to 2024 described a case in which a donor from Guatemala tested positive for strongyloides serology at the time of death. Three of the four organ recipients received preventive ivermectin and did fine. The heart recipient did not receive prophylaxis, developed symptoms about 11 weeks after transplant, and died at 87 days despite treatment.30Emerging Infectious Diseases. Investigation of Donor-Transmitted Strongyloides stercoralis Infections in Solid Organ Transplant Recipients, United States, 2012–2024 In a broader CDC review of seven donor-derived transmission investigations, 11 of 20 recipients became symptomatic, with a median time from transplant to diagnosis of about 13 weeks. Two died, one from hyperinfection and one from disseminated disease involving the central nervous system.31American Journal of Transplantation. Donor-Derived Strongyloides stercoralis Infection in Solid Organ Transplant Recipients: Centers for Disease Control and Prevention Experience and Targeted Donor Screening Strategy These cases have pushed transplant programs toward screening donors from endemic areas with serology before organs are harvested, but universal screening is not yet standard practice everywhere.
Mass Drug Administration and the Road to Control
Unlike soil-transmitted helminths that have been targeted by large-scale deworming programs for years, strongyloides has historically been left out. Albendazole and mebendazole, the drugs most commonly distributed in mass deworming campaigns, are not very effective against strongyloides. Ivermectin is what works, but until recently it was not routinely included in community-based treatment programs. Modeling of strongyloides transmission dynamics suggests that the frequency of mass drug administration needed to drive prevalence down to very low levels depends on how much of the parasite’s reproduction comes from autoinfection versus environmental transmission. In settings where environmental transmission is high, treatments may need to happen once or twice a year with high community coverage and good individual compliance over multiple rounds.32PubMed Central. The transmission dynamics of Strongyloides stercoralis and the impact of mass drug administration
Animal Reservoirs and Zoonotic Spillover
Strongyloides is not exclusively a human parasite. Dogs are important hosts for S. stercoralis, and genetic studies have confirmed that the same haplotypes of the worm circulate between people, dogs, and non-human primates. A recent molecular survey in the Central African Republic found that the dominant human haplotype also appeared in dogs and apes, while a related species, S. fuelleborni, was present in all three host groups. The sharing of species and specific genetic variants points to active zoonotic transmission, meaning dogs and wild primates serve as reservoirs that could re-seed human infections even after treatment campaigns.33PubMed Central. Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016-202234PubMed Central. Strongyloides in non-human primates: significance for public health control
There is a separate and more mysterious Strongyloides species that affects infants in Papua New Guinea. S. fuelleborni subspecies kellyi has been implicated in “swollen belly syndrome,” a rapidly fatal disease of infants around two months old characterized by a distended abdomen, eosinophilia, diarrhea, and respiratory distress. Recent genetic work detected a Strongyloides genospecies closely related to S. ransomi, a pig parasite that causes a strikingly similar protein-losing gut disease in newborn piglets. This raises the possibility that at least some cases of swollen belly syndrome in human infants could involve zoonotic spillover from pigs rather than the previously suspected S. fuelleborni kellyi alone.35Emerging Infectious Diseases. Insights into Infant Strongyloidiasis, Papua New Guinea The question remains unresolved, but it underscores how much basic biology of this parasite group is still being worked out, even as it quietly persists in millions of people around the world.